Rebecca Louise DAVIE,Hannah Joy EDWARDS,David Michael EVANS,Simon Teanby HODGSON,Stephen John PETHEN,David Philip BOOKER
申请号：
US16301192
公开号：
US20190218205A1
申请日:
2017.05.31
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides a selection of compounds of formula (I): (I) compositions comprising such compounds； the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated)； and methods of treating patients with such compounds； wherein R5, R6, R7, A, B, W, X, Y and Z are as defined herein.
